A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties. - Wikidata - awgldk - TriplyDB

A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties.

A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties.

http://www.wikidata.org/entity/Q37269467

about

The PAX2-null immunophenotype defines multiple lineages with common expression signatures in benign and neoplastic oviductal epithelium.Mucin 1-mediated chemo-resistance in lung cancer cells.Prognostic values of aldehyde dehydrogenase 1 isoenzymes in ovarian cancer.Cytotoxic Effects of Strawberry, Korean Raspberry, and Mulberry Extracts on Human Ovarian Cancer A2780 Cells.Targeting of Wnt/β-Catenin by Anthelmintic Drug Pyrvinium Enhances Sensitivity of Ovarian Cancer Cells to Chemotherapy.Elevated expression of JMJD6 is associated with oral carcinogenesis and maintains cancer stemness properties Withaferin A (WFA) inhibits tumor growth and metastasis by targeting ovarian cancer stem cells.Combination of a thioxodihydroquinazolinone with cisplatin eliminates ovarian cancer stem cell-like cells (CSC-LCs) and shows preclinical potential.

P2860

Q34498581-4B5DA7F3-1E48-4BF2-B165-ABFCD57034FB Q36507586-BA6E0064-4C84-44AC-A7E2-C7A9003824AA Q36798021-58C6629E-87CF-4E6A-B04B-1F36918C29DB Q37564935-FA79964B-0198-46BF-9FF6-501CB7469232 Q37606422-6F7F44C6-1889-4694-92D1-8DEC03BA846A Q38813733-0F3C609D-95B4-408E-967E-8389DD60786B Q46070440-8C97CF99-A438-4E1E-936F-1DE3F3B7AF86 Q49787658-C4F062F6-FBC7-4EA5-9592-6F351B625FBB

P2860

A2780 human ovarian cancer cells with acquired paclitaxel resistance display cancer stem cell properties.

http://www.wikidata.org/entity/Q37269467

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on 06 September 2013

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

A2780 human ovarian cancer cel ...... y cancer stem cell properties.

@en

A2780 human ovarian cancer cel ...... y cancer stem cell properties.

@nl

type

label

A2780 human ovarian cancer cel ...... y cancer stem cell properties.

@en

A2780 human ovarian cancer cel ...... y cancer stem cell properties.

@nl

prefLabel

A2780 human ovarian cancer cel ...... y cancer stem cell properties.

@en

A2780 human ovarian cancer cel ...... y cancer stem cell properties.

@nl

P1433

Q37269467-2E045A57-C2D3-4339-9481-AE64758A0051

P1476

Q37269467-DAA1166E-D14F-48F8-A788-2FB7F516A138

P2093

Q37269467-11C301F3-5F1C-48C3-AF5F-1AEE6DE5F5C9

Q37269467-13C51D3C-510B-4E2A-A207-F7AD81E6EA09

Q37269467-5B10A9A7-53C0-47BE-92E7-A7DEF104F854

Q37269467-5DE6377A-5431-4B16-BF55-A93D485B93FA

Q37269467-5E7616BC-D994-4F5A-A377-0493DA57FA25

Q37269467-659AF341-885E-4C92-AD35-136339AD8382

Q37269467-72B24147-BF24-4ED0-9393-14000D3388F2

Q37269467-AD421138-7FEF-4331-ACB5-232B5D64088C

Q37269467-BA41A9F9-8EB5-4257-B2F2-E47BC49A2AC9

Q37269467-C129FF11-BFD6-45AD-93EF-AB422A184922

P2860

Q37269467-1BD6667A-D2B9-4006-AB91-713CBAED8B07

Q37269467-1C1F3EC4-22B3-4E47-AB6E-D13F1AF6BD07

Q37269467-22028F1C-B65D-4795-B089-4007723DC772

Q37269467-2A02DB4B-4C34-44B3-88DA-9BA61A0A2E19

Q37269467-34024DF5-2C04-42A3-B39F-B6EE4D75D581

Q37269467-40025B31-6A7A-4AFA-8094-034709DA2D73

Q37269467-440CBD1E-8479-48D8-B870-8017FFAE7693

Q37269467-4E6D049F-50BF-40BA-8E4D-D8F0A3949F01

Q37269467-593434C0-C26A-40BA-9655-E8FC996573E6

Q37269467-64FBCA47-D29A-44A0-ABA3-D2BFA0A39056

P304

Q37269467-3FEAF227-2084-4201-9854-219253C840CA

P31

Q37269467-AD1D9917-FA78-4C0C-8C97-883AFC0B94D8

P356

Q37269467-F234149B-CEBA-45D4-8879-D449EEF4999B

P433

Q37269467-475A02EB-9266-42BA-B3F4-C6AFFCF229EF

P478

Q37269467-9597017E-5527-48C7-A432-736BED6A40E2

P50

Q37269467-764E5848-9E79-4B2D-9CA6-D0300C2D0D4F

P577

Q37269467-66B259D1-ABA0-4C1E-833C-73551E438315

P5875

Q37269467-569A5CB6-8A5A-4245-ADD4-4CBBDB59A83E

P698

Q37269467-D3962963-AEE9-4767-B05A-66B47E778A67

P921

Q37269467-9C66BC90-276E-433C-B4CE-AC83599F4CAB

P932

Q37269467-0612B0E1-3A2A-461A-93B0-9E9A91C23ADD

P356

P1433

Oncology Letters

P1476

A2780 human ovarian cancer cel ...... ay cancer stem cell properties

@en

P2093

Dong Hua

http://www.w3.org/2001/XMLSchema#string

Fangfang DU

http://www.w3.org/2001/XMLSchema#string

Jian Jin

http://www.w3.org/2001/XMLSchema#string

Li Jiang

http://www.w3.org/2001/XMLSchema#string

Teng Wang

http://www.w3.org/2001/XMLSchema#string

Tingting Hong

http://www.w3.org/2001/XMLSchema#string

Xiaofeng Han

http://www.w3.org/2001/XMLSchema#string

Xiaohong Wu

http://www.w3.org/2001/XMLSchema#string

Xin Ma

http://www.w3.org/2001/XMLSchema#string

Yanjun Liu

http://www.w3.org/2001/XMLSchema#string

P2860

Distinct expression levels and patterns of stem cell marker, aldehyde dehydrogenase isoform 1 (ALDH1), in human epithelial cancers

Aldehyde dehydrogenase activity selects for lung adenocarcinoma stem cells dependent on notch signaling

Cancer stem cells--perspectives on current status and future directions: AACR Workshop on cancer stem cells

Association of reactive oxygen species levels and radioresistance in cancer stem cells

High ALDH activity identifies chemotherapy-resistant Ewing's sarcoma stem cells that retain sensitivity to EWS-FLI1 inhibition

Stem cell pathways contribute to clinical chemoresistance in ovarian cancer

High-dose chemotherapy with autologous hematopoietic stem-cell transplantation in metastatic breast cancer: overview of six randomized trials.

Current management strategies for ovarian cancer.

Ovarian cancer stem cell markers: prognostic and therapeutic implications.

The emerging role of the phosphatidylinositol 3-kinase/Akt/mammalian target of rapamycin signaling network in normal myelopoiesis and leukemogenesis.

P304

1295-1298

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3892/OL.2013.1568

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P50

P577

2013-09-06T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258216342

http://www.w3.org/2001/XMLSchema#string

P698

24179511

http://www.w3.org/2001/XMLSchema#string

P921

P932

3813719

http://www.w3.org/2001/XMLSchema#string